bronco-pneumologia
English translation: pulmonology
| 05:32 Feb 9, 2010 |
| Italian to English translations [PRO] Medical - Medical (general) / Medical Specialties | |||||||
|---|---|---|---|---|---|---|---|
|
| ||||||
|  Selected response from: Alexander Cormack (X) Italy Local time: 12:47 | ||||||
Grading comment
| |||||||
| Summary of answers provided | ||||
|---|---|---|---|---|
| 4 +6 | pulmonology |
| ||
| 4 +2 | broncho pneumology |
| ||
| 5 | Bronchopneumology or Bronco-pneumology |
| ||
| 3 | bronco-lung specialization |
|
| Discussion entries: 1 | |
|---|---|
Answers
14 mins confidence: 
bronco-lung specialization Explanation: lung specialization seems more accurate |
| |
| Login to enter a peer comment (or grade) | ||
37 mins confidence: peer agreement (net): +2
peer agreement (net): +2broncho pneumology Explanation: Pneumology : The science which treats of the lungs. -------------------------------------------------- Note added at 49 minute (2010-02-09 06:22:20 GMT) -------------------------------------------------- Rottapharm|Madaus is a multinational pharmaceutical group of Italian capital with its headquarters and research centre in Monza and branches in over 85 countries. Since its creation, Rottapharm has distinguished itself in its commitment in designing, development and marketing of innovative drugs for the treatment of specific pathologies. Currently, research is focused on gastroenterology; bronco-pneumology, psychiatry, rheumatology, gynecology, cardiology and oncology. Rottapharm|Madaus is also present in the market of personal care products distributed in pharmacies – where it holds a leadership position – and in the field of nutraceutics. Rottapharm|Madaus finished the year of 2007 with a revenue of 551 million Euros and an EBITDA of 131 million Euros. -------------------------------------------------- Note added at 52 minute (2010-02-09 06:24:59 GMT) -------------------------------------------------- Asthma self-management programmes in a population of Italian children: a multicentric study. Italian Study Group on Asthma Self-Management Programmes R Ronchetti, L Indinnimeo, E Bonci, A Corrias, D Evans, M Hindi-Alexander, F Midulla, R Pulejo, and MP Villa This study was designed to answer three main questions: 1) Does asthma self-management education reduce asthma morbidity? 2) Are the two programmes "Living With Asthma" and "Open Airways" equally effective in doing so? 3) Is a shortened version of these programmes (4 weeks) as effective as the longer original programme (8 weeks)? Twelve Italian centres of paediatric bronchopneumology selected 312 children with asthma, who were stratified by disease severity, gender and age, and then randomly assigned to an Experimental group which received an educational programme or to a Comparison group, which did not. Of the 312 children selected, 209 (114 Experimental and 95 Comparison) completed the educational protocol and a 1 year follow-up. Data recorded during the last 2 months of follow-up, 10 months after the educational intervention, showed that the Experimental group required significantly fewer emergency treatments: this reduction was more evident in the more severe asthma cases. In the Experimental, but not in the Comparison group, patients with more severe asthma consumed more medications than patients with milder asthma "Open Airways" yielded, in some cases, better results than "Living with Asthma": but a type 2 error is possible. The standard and the shortened programmes proved equally effective. In conclusion, following education, regardless of receiving a short or long educational programme, asthma patients use emergency care services less and use medications more appropriately in comparison with standard care without education. This suggests that short educational programmes can be highly cost-effective in children with asthma. |
| |||||||||||||
1 hr confidence: peer agreement (net): +6
| ||||||||||||||
